These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17008937)

  • 1. Phenotypic diversity in delayed drug hypersensitivity: an immunologic explanation.
    Meth MJ; Sperber KE
    Mt Sinai J Med; 2006 Sep; 73(5):769-76. PubMed ID: 17008937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type IV of hypersensitivity and its subtypes].
    Czarnobilska E; Obtułowicz K; Wsołek K
    Przegl Lek; 2007; 64(7-8):506-8. PubMed ID: 18409354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed drug hypersensitivity reactions - new concepts.
    Posadas SJ; Pichler WJ
    Clin Exp Allergy; 2007 Jul; 37(7):989-99. PubMed ID: 17581192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of T cells in nonimmediate allergic drug reactions.
    Rozieres A; Vocanson M; Saïd BB; Nosbaum A; Nicolas JF
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):305-10. PubMed ID: 19474707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug hypersensitivity reactions involving skin.
    Hausmann O; Schnyder B; Pichler WJ
    Handb Exp Pharmacol; 2010; (196):29-55. PubMed ID: 20020258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed drug hypersensitivity reactions.
    Pichler WJ
    Ann Intern Med; 2003 Oct; 139(8):683-93. PubMed ID: 14568857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence.
    Torres MJ; Mayorga C; Fernández TD; Cornejo-García JA; Antúnez C; Valenzuela M; Del Prado MF; Rodriguez-Pena R; Blanca M
    Int J Immunopathol Pharmacol; 2006; 19(1):119-30. PubMed ID: 16569350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonimmediate reactions to betalactams.
    Lopez S; Blanca-Lopez N; Cornejo-Garcia JA; Canto G; Torres MJ; Mayorga C; Blanca M
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):310-6. PubMed ID: 17620822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical heterogeneity of drug hypersensitivity.
    Roujeau JC
    Toxicology; 2005 Apr; 209(2):123-9. PubMed ID: 15767024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8. Drug allergy.
    Greenberger PA
    J Allergy Clin Immunol; 2006 Feb; 117(2 Suppl Mini-Primer):S464-70. PubMed ID: 16455348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug hypersensitivity reactions: pathomechanism and clinical symptoms.
    Pichler WJ; Adam J; Daubner B; Gentinetta T; Keller M; Yerly D
    Med Clin North Am; 2010 Jul; 94(4):645-64, xv. PubMed ID: 20609855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions.
    Beeler A; Engler O; Gerber BO; Pichler WJ
    J Allergy Clin Immunol; 2006 Feb; 117(2):455-62. PubMed ID: 16461148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
    Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular pathophysiology of cutaneous drug reactions.
    Pichler WJ; Yawalkar N; Britschgi M; Depta J; Strasser I; Schmid S; Kuechler P; Naisbitt D
    Am J Clin Dermatol; 2002; 3(4):229-38. PubMed ID: 12010068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams.
    Rodriguez-Pena R; Lopez S; Mayorga C; Antunez C; Fernandez TD; Torres MJ; Blanca M
    J Allergy Clin Immunol; 2006 Oct; 118(4):949-56. PubMed ID: 17030251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests.
    Torres MJ; Mayorga C; Blanca M
    J Investig Allergol Clin Immunol; 2009; 19(2):80-90. PubMed ID: 19476012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial damage in all types of T-lymphocyte-mediated drug-induced eruptions.
    Verneuil L; Leboeuf C; Vidal JS; Ratajczak P; Comoz F; Ameisen JC; Janin A
    Arch Dermatol; 2011 May; 147(5):579-84. PubMed ID: 21576578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced exanthems.
    Yawalkar N
    Toxicology; 2005 Apr; 209(2):131-4. PubMed ID: 15767025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mechanisms in drug allergy.
    Roujeau JC
    Allergol Int; 2006 Mar; 55(1):27-33. PubMed ID: 17075283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunological and clinical spectrum of delayed drug-induced exanthems.
    Lerch M; Pichler WJ
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):411-9. PubMed ID: 15349041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.